Infliximab for Kawasaki syndrome

J Pediatr. 2006 Sep;149(3):426; author reply 426. doi: 10.1016/j.jpeds.2005.07.039.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Asian People*
  • Child, Preschool
  • Humans
  • Infliximab
  • Male
  • Mucocutaneous Lymph Node Syndrome / drug therapy*
  • Mucocutaneous Lymph Node Syndrome / genetics

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab